arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

CIRTRAN CORP

CIRX
— Price unavailable
Consumer Staples ·Beverages ·USBeverages
51 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
40
Health
Weak
Bearish
auto_awesome

Analytical Summary

CIRTRAN CORP faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap —
Dividend Yield —
Revenue Growth 595.6% ↗
Op. Margin 13.7% ↗
ROIC -0.6% ↘
FCF / Share $0.04 ↗
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity —
info Valuation on last close.

51-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.17M
↑ +595.6% —
Net Income Profit after all expenses
$2.22M
— 0.0% —
Operating Margin Operating profit as % of sales
13.7%
↑ +340.8% 21th
FCF / Share Free cash flow per share
$0.04
↑ +410.8% —
Long-Term Debt Long-term obligations
$1.89M
↓ -27.0% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑
12
Returns
49
Cash Quality ↓
85

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 13 years · 51 quarters